SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:41 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% | -5,837,126 (Position Closed) | Filing |
| 2024-02-13 11:44 am Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,837,126 9.500% | 2,388,851 (+69.28%) | Filing |
| 2023-01-03 4:58 pm Purchase | 2022-12-21 | 13G | Terns Pharmaceuticals, Inc. TERN | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 7.000% | 3,448,275 (New Position) | Filing |